Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • CTLA-4 Antigen
  • Cryosurgery
  • Prostatic Neoplasms

abstract

  • This phase II study of dasatinib and paclitaxel was stopped early because of slow accrual but showed some clinical activity. Further study is not planned.

publication date

  • January 2018

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.clbc.2018.03.010

PubMed ID

  • 29680193

Additional Document Info